NCMAG103 Lenalidomide advice document: October 2022
Posted on:
Document Type
Process guidance
Summary
Adults with previously untreated multiple myeloma who are not eligible for transplant and are suitable for thalidomide-containing regimen. (On-label use and off-patent medicines)
Decision: support